Ondansetron 8mg
Sponsors
Dr. Marco L.A. Sivilotti, Icahn School of Medicine at Mount Sinai, Assiut University, University of Nottingham, Mayo Clinic
Conditions
Adverse Effects in the Therapeutic Use of AnaestheticAnesthesia ComplicationAtrial FibrillationCaesarean SectionCannabis Use DisorderCyclic Vomiting SyndromeDelayed Gastric EmptyingDiabetes Mellitus
Phase 1
Phase 2
Anti-shivering Effect of Ondansetron
NCT03530007
Start: 2018-05-15End: 2018-09-15Target: 120Updated: 2018-05-21
Effects of Ondansetron on Gastrointestinal Sensorimotor Dysfunctions in Diabetes Mellitus and Dyspepsia
RecruitingNCT03865290
Start: 2019-04-02End: 2028-03-31Target: 150Updated: 2025-04-25
Evaluating Neostigmine Effect on Reducing Gastric Residual Volume as Compared With Metoclopramide and Ondansetron
CompletedNCT05342818
Start: 2022-04-15End: 2022-10-17Updated: 2022-10-20
Phase 3
The Effect of Ondansetron on Spinal Anesthesia in Caesarean Section
NCT03931863
Start: 2019-05-22End: 2022-05-31Target: 180Updated: 2021-01-20
Haloperidol, Droperidol, Ondansetron in Cannabis Hyperemesis
TerminatedNCT05065567
Start: 2021-08-30End: 2023-11-20Updated: 2025-05-21
Ondansetron and Gabapentin in Preventing Postoperative Nausea and Vomiting After Laparoscopic Sleeve Gastrectomy
CompletedNCT05620641
Start: 2022-10-01End: 2025-04-01Updated: 2025-04-17
Phase 4
Haloperidol Versus Ondansetron for Cannabis Hyperemesis Syndrome (HaVOC)
CompletedNCT03056482
Start: 2017-05-21End: 2019-07-07Updated: 2024-04-03
Effects of Ondansetron Dose and Timing on Post-operative Nausea and Vomiting
CompletedNCT03297021
Start: 2017-10-23End: 2019-04-05Updated: 2020-07-20
Mode of Action of Ondansetron, a 5-HT Receptor 3 Antagonist, in Lactulose Induced Diarrhoea
CompletedNCT03833999
Start: 2018-10-16End: 2019-06-27Updated: 2019-11-27
Nefopam Versus Ondansteron for Prevention of Post Spinal Shivering.
NCT04870541
Start: 2020-12-01End: 2021-12-01Target: 150Updated: 2021-05-03
Ephedrine Versus Ondansetron During Cesarean Delivery
CompletedNCT05127876
Start: 2022-01-10End: 2022-03-06Updated: 2022-09-09
Evaluating the Effectiveness of Ondansetron Versus Dexamethasone Versus Placebo for the Control of Intraoperative Nausea and Vomiting in Patients Undergoing Lower-segment Caesarean Section Under Spinal Anesthesia
NCT05583214
Start: 2022-10-31End: 2023-01-31Target: 90Updated: 2022-10-18
Ondansetron for the Management of Atrial Fibrillation
RecruitingNCT05844501
Start: 2025-04-22End: 2027-12-31Target: 80Updated: 2026-02-04
Aprepitant and Ondansetron Monotherapy or Combination for Postoperative Nausea and Vomiting in Thyroid Cancer
CompletedNCT06697782
Start: 2024-07-01End: 2025-01-01Updated: 2025-01-22
Ondansetron and Dexamethasone for Prevention of PDPH, Nausea, and Vomiting
CompletedNCT07068230
Start: 2018-10-01End: 2019-10-01Updated: 2025-07-18
Unknown Phase
Granisteron Versus Ondansetron for Prophylaxis Against Post-Spinal Anesthesia Shivering: a Randomized Controlled Study
NCT04294992
Start: 2020-04-01End: 2020-09-30Target: 180Updated: 2020-03-04
Antiemetic Prophylaxis With Fosaprepitant and Ondansetron in Patients Undergoing Thoracic Surgery
NCT05881486
Start: 2023-06-30End: 2023-06-30Target: 234Updated: 2023-06-06
Effectiveness of Nalbuphine as an Adjuvant to Subarachnoid Block on Postoperative Analgesia in TURP Surgery
CompletedNCT06153602
Start: 2023-12-07End: 2024-11-28Updated: 2025-01-13
Efficacy of Co-Spinal Ondansetron In Inguinal Herniorrhaphy
Enrolling by invitationNCT06850740
Start: 2025-03-15End: 2025-08-15Target: 46Updated: 2025-04-30